VBI Vaccines Inc.

NASDAQ:VBIV

0.30

-0.01 (-3.75%)

7:35:25 PM EDT: $0.31 +0.01 (+2.31%)

Products

VBI Vaccines Announces Submission of Biologics License Application to FDA for 3-Antigen Prophylactic Hepatitis B Vaccine

Published: 12/01/2020 13:08 GMT

VBIV

VBI Vaccines Inc. (VBIV) - Vbi Vaccines Announces Submission of Biologics License Application to FDA for 3-antigen Prophylactic Hepatitis B Vaccine.